TAK-875 Chemical Structure
GSK1292263 is a novel GPR119 receptor agonist used for the treatment of type 2 diabetes.
Andarine (GTX-007) is an investigational selective androgen receptor modulator (SARM) and an active partial agonist.
An androgen receptor modulator (SARM)
Anastrozole inhibits the enzyme aromatase.
Fulvestrant (Faslodex) is a Synthetic estrogen receptor antagonist(SERD)
Exemestane was found to inhibit human placental aromatase with IC50 of 42 nM.
Finasteride is an inhibitor of steroid Type II 5α-reductase.
Dutasteride is a 5-alpha-reductase inhibitor
A selective estrogen receptor modulator(SERM). raloxifene inhibited the proliferation of the human breast cancer cell line, MCF-7, with IC50=0.2 nM
Letrozole is an Aromatase inhibitor. CGS 20267 is a new non-steroidal compound which potently inhibits aromatase in vitro (IC50 of 11.5 nM) and in vivo (ED50 of 1–3 μg/kg p.o.)
TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with an EC50 of 0.072 μM. TAK-875 is a new agent applied in the treatment of type 2 diabetes. TAK-875 not only elevated the levels of intra-cellular inositol monophosphate as well as calcium contents in rat insulinoma INS-1 833/15 cells but also improved the tolerance of glucose and amplified insulin secretion when orally administered in tolerance test. However, TAK-875 didn’t increase the secretion of insulin and cause hypoglycemia when 30 mg/kg dosage of TAK-875 was given in fasted normal Sprague Dawley rats. Conversely, TAK-875 with a dosage of 10 mg/kg (p.o.) not only significantly improved plasma insulin levels but also decreased fasting hyperglycemia in male Zucker diabetic fatty rats. [1][2]
| Molecular Weight (WM): | 533.63 |
|---|---|
| Formula: | C29H32O7S.1/2H2O |
| CAS No.: | 1000413-72-8 |
| Synonyms: |
N/A
|
| Dissolve in (25°C): | DMSO ≥105mg/mL |
| Water <1mg/mL | |
| Ethanol ≥11mg/mL | |
| Storage: | 2 years-20°CPowder |
| 1 week-4°Cin DMSO | |
| 1 month-80°in DMSO |
A collection of 864 bioactive compounds
A collection of 481 inhibitors
A collection of 194 kinase inhibitors
A collection of 85 tyrosine kinase inhibitors.
A collection of 426 FDA approved drugs
A collection of 139 natural products
A collection of 40 chemotherapeutic agents
A unique collection of 17 small molecule modulators
A unique collection of 47 small molecule inhibitors
A unique collection of 63 GPCR small molecules
Keywords:buy TAK-875 | TAK-875 supplier | purchase TAK-875 | TAK-875 cost | TAK-875 manufacturer | order TAK-875 | TAK-875 distributor